Table of Contents for the Digital Edition of Pharmaceutical Technology - February 2012 Pharmaceutical Technology - February 2012 Table of Contents Sustainable Investment FDA’s Social Media Insight Shipping With the Enemy? In the Field In the Spotlight FDA and Justice Department Address Drug Quality Concerns Single-Use High-Capacity Membrane Chromatography Reducing Common Cause Variation Drug-Substance Development and Manufacture Optimizing Adjuvant Filtration Expanding Capabilities in the Pharmaceutical Cold Chain Evaluating Impurities in Drugs (Part I of III) ICH Implementation Support Biomanufacturing Outlook Industry Pipeline Showcase/Marketplace Ad Index Saving the Next Generation of Regulatory Scientists Pharmaceutical Technology - February 2012 Pharmaceutical Technology - February 2012 - (Page CT1) Pharmaceutical Technology - February 2012 - (Page CT2) Pharmaceutical Technology - February 2012 - Pharmaceutical Technology - February 2012 (Page Cover1) Pharmaceutical Technology - February 2012 - Pharmaceutical Technology - February 2012 (Page Cover2) Pharmaceutical Technology - February 2012 - Pharmaceutical Technology - February 2012 (Page 3) Pharmaceutical Technology - February 2012 - Pharmaceutical Technology - February 2012 (Page 4) Pharmaceutical Technology - February 2012 - Pharmaceutical Technology - February 2012 (Page 5) Pharmaceutical Technology - February 2012 - Table of Contents (Page 6) Pharmaceutical Technology - February 2012 - Table of Contents (Page 7) Pharmaceutical Technology - February 2012 - Table of Contents (Page 8) Pharmaceutical Technology - February 2012 - Table of Contents (Page 9) Pharmaceutical Technology - February 2012 - Sustainable Investment (Page 10) Pharmaceutical Technology - February 2012 - Sustainable Investment (Page 11) Pharmaceutical Technology - February 2012 - FDA’s Social Media Insight (Page 12) Pharmaceutical Technology - February 2012 - FDA’s Social Media Insight (Page 13) Pharmaceutical Technology - February 2012 - Shipping With the Enemy? (Page 14) Pharmaceutical Technology - February 2012 - Shipping With the Enemy? (Page 15) Pharmaceutical Technology - February 2012 - In the Field (Page 16) Pharmaceutical Technology - February 2012 - In the Field (Page 17) Pharmaceutical Technology - February 2012 - In the Field (Page 18) Pharmaceutical Technology - February 2012 - In the Field (Page 19) Pharmaceutical Technology - February 2012 - In the Field (Page 20) Pharmaceutical Technology - February 2012 - In the Field (Page 21) Pharmaceutical Technology - February 2012 - In the Spotlight (Page 22) Pharmaceutical Technology - February 2012 - In the Spotlight (Page 23) Pharmaceutical Technology - February 2012 - FDA and Justice Department Address Drug Quality Concerns (Page 24) Pharmaceutical Technology - February 2012 - FDA and Justice Department Address Drug Quality Concerns (Page 25) Pharmaceutical Technology - February 2012 - FDA and Justice Department Address Drug Quality Concerns (Page 26) Pharmaceutical Technology - February 2012 - FDA and Justice Department Address Drug Quality Concerns (Page 27) Pharmaceutical Technology - February 2012 - FDA and Justice Department Address Drug Quality Concerns (Page 28) Pharmaceutical Technology - February 2012 - FDA and Justice Department Address Drug Quality Concerns (Page 29) Pharmaceutical Technology - February 2012 - Single-Use High-Capacity Membrane Chromatography (Page 30) Pharmaceutical Technology - February 2012 - Single-Use High-Capacity Membrane Chromatography (Page 31) Pharmaceutical Technology - February 2012 - Reducing Common Cause Variation (Page 32) Pharmaceutical Technology - February 2012 - Reducing Common Cause Variation (Page 33) Pharmaceutical Technology - February 2012 - Drug-Substance Development and Manufacture (Page 34) Pharmaceutical Technology - February 2012 - Drug-Substance Development and Manufacture (Page 35) Pharmaceutical Technology - February 2012 - Drug-Substance Development and Manufacture (Page 36) Pharmaceutical Technology - February 2012 - Drug-Substance Development and Manufacture (Page 37) Pharmaceutical Technology - February 2012 - Optimizing Adjuvant Filtration (Page 38) Pharmaceutical Technology - February 2012 - Optimizing Adjuvant Filtration (Page 39) Pharmaceutical Technology - February 2012 - Optimizing Adjuvant Filtration (Page 40) Pharmaceutical Technology - February 2012 - Optimizing Adjuvant Filtration (Page 41) Pharmaceutical Technology - February 2012 - Expanding Capabilities in the Pharmaceutical Cold Chain (Page 42) Pharmaceutical Technology - February 2012 - Expanding Capabilities in the Pharmaceutical Cold Chain (Page 43) Pharmaceutical Technology - February 2012 - Expanding Capabilities in the Pharmaceutical Cold Chain (Page 44) Pharmaceutical Technology - February 2012 - Expanding Capabilities in the Pharmaceutical Cold Chain (Page 45) Pharmaceutical Technology - February 2012 - Evaluating Impurities in Drugs (Part I of III) (Page 46) Pharmaceutical Technology - February 2012 - Evaluating Impurities in Drugs (Part I of III) (Page 47) Pharmaceutical Technology - February 2012 - Evaluating Impurities in Drugs (Part I of III) (Page 48) Pharmaceutical Technology - February 2012 - Evaluating Impurities in Drugs (Part I of III) (Page 49) Pharmaceutical Technology - February 2012 - Evaluating Impurities in Drugs (Part I of III) (Page 50) Pharmaceutical Technology - February 2012 - Evaluating Impurities in Drugs (Part I of III) (Page 51) Pharmaceutical Technology - February 2012 - ICH Implementation Support (Page 52) Pharmaceutical Technology - February 2012 - ICH Implementation Support (Page 53) Pharmaceutical Technology - February 2012 - Biomanufacturing Outlook (Page 54) Pharmaceutical Technology - February 2012 - Biomanufacturing Outlook (Page 55) Pharmaceutical Technology - February 2012 - Biomanufacturing Outlook (Page 56) Pharmaceutical Technology - February 2012 - Biomanufacturing Outlook (Page 57) Pharmaceutical Technology - February 2012 - Industry Pipeline (Page 58) Pharmaceutical Technology - February 2012 - Industry Pipeline (Page 59) Pharmaceutical Technology - February 2012 - Industry Pipeline (Page 60) Pharmaceutical Technology - February 2012 - Industry Pipeline (Page 61) Pharmaceutical Technology - February 2012 - Showcase/Marketplace (Page 62) Pharmaceutical Technology - February 2012 - Showcase/Marketplace (Page 63) Pharmaceutical Technology - February 2012 - Ad Index (Page 64) Pharmaceutical Technology - February 2012 - Ad Index (Page 65) Pharmaceutical Technology - February 2012 - Saving the Next Generation of Regulatory Scientists (Page 66) Pharmaceutical Technology - February 2012 - Saving the Next Generation of Regulatory Scientists (Page Cover3) Pharmaceutical Technology - February 2012 - Saving the Next Generation of Regulatory Scientists (Page Cover4) http://digital.findpharma.com/nxtbooks/advanstar/pt_201205_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201205 http://digital.findpharma.com/nxtbooks/advanstar/pt_201204 http://digital.findpharma.com/nxtbooks/advanstar/pt_201203_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201203 http://digital.findpharma.com/nxtbooks/advanstar/pt_201202_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201202 http://digital.findpharma.com/nxtbooks/advanstar/pt_201201 http://digital.findpharma.com/nxtbooks/advanstar/pt_201112 http://digital.findpharma.com/nxtbooks/advanstar/pt_201111 http://digital.findpharma.com/nxtbooks/advanstar/pt_201111_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201110 http://digital.findpharma.com/nxtbooks/advanstar/pt_201109 http://digital.findpharma.com/nxtbooks/advanstar/pt_201109_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201108 http://digital.findpharma.com/nxtbooks/advanstar/pt_201108_supplmnt http://digital.findpharma.com/nxtbooks/advanstar/pt_201107 http://digital.findpharma.com/nxtbooks/advanstar/pt_201106 http://digital.findpharma.com/nxtbooks/advanstar/pt_201105_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201105 http://digital.findpharma.com/nxtbooks/advanstar/pt_201104 http://digital.findpharma.com/nxtbooks/advanstar/pt_201104_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201103 http://digital.findpharma.com/nxtbooks/advanstar/pt_201102 http://digital.findpharma.com/nxtbooks/advanstar/pt_201101 http://digital.findpharma.com/nxtbooks/advanstar/pt_201012 http://digital.findpharma.com/nxtbooks/advanstar/pt_201011 http://digital.findpharma.com/nxtbooks/advanstar/pt_201010 http://digital.findpharma.com/nxtbooks/advanstar/pt_201009 http://digital.findpharma.com/nxtbooks/advanstar/pt_201008 http://digital.findpharma.com/nxtbooks/advanstar/pt_201007 http://digital.findpharma.com/nxtbooks/advanstar/pt_201006 http://digital.findpharma.com/nxtbooks/advanstar/pt_201005 http://digital.findpharma.com/nxtbooks/advanstar/pt_201004 http://digital.findpharma.com/nxtbooks/advanstar/pt_201003 http://digital.findpharma.com/nxtbooks/advanstar/pt201002 http://digital.findpharma.com/nxtbooks/advanstar/pt_201001 http://digital.findpharma.com/nxtbooks/advanstar/pt_200912 http://digital.findpharma.com/nxtbooks/advanstar/pt_200911 http://digital.findpharma.com/nxtbooks/advanstar/pt10_2009 http://digital.findpharma.com/nxtbooks/advanstar/pt_200909 http://digital.findpharma.com/nxtbooks/advanstar/pt_200908 http://digital.findpharma.com/nxtbooks/advanstar/pt_200907 http://digital.findpharma.com/nxtbooks/advanstar/pt_200906 http://digital.findpharma.com/nxtbooks/advanstar/pt_200905 http://www.nxtbook.com/nxtbooks/advanstar/pt_200904 http://www.nxtbook.com/nxtbooks/advanstar/pt_200903 http://www.nxtbook.com/nxtbooks/advanstar/pt_200902 http://www.nxtbook.com/nxtbooks/advanstar/pt_200901 http://www.nxtbookMEDIA.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.